What You Should Know:
- Clarapath, a robotics company aimed at catalyzing change in the way pathology laboratories process human and animal tissue acquires Mountain View, CA-based Crosscope. Financial details of the acquisition were not disclosed.
- Crosscope is a digital pathology company with a turnkey imaging solution providing best-in-class workflow tools and slide management along with artificial intelligence (AI) and machine learning (ML) technology to assist pathologists with better
Read More
Artificial Intelligence in Healthcare | News, Analysis, Insights - HIT Consultant
Aiberry Secures $8M for AI-Powered Mental Health Screenings
What You Should Know:
- Aiberry (pronounced “I” + “berry”), an AI-powered mental health screening pioneer today announced that it has secured $8M in seed funding led by Confluence Capital Group, Inc. (CCG) with participation from the VC fund Ascension AI. This brings total funding to $10M
- The company plans to use the latest round of funding to accelerate the adoption of the Aiberry platform, which uses an AI-powered therapeutic assistant to conduct a conversation to detect mental health
Read More
Improving The Digital Experience – for Both Patient and Employee
It’s a tired, old saw: Healthcare organizations are woefully behind when it comes to technology, automation and digital experiences.
Leaders are sick of hearing it. But that doesn’t make it any less true.
Current market pressures, however, compel hospitals, health systems and medical practices to reconsider their hesitancy in embracing these innovations. A combination of consumer demand and acute, unrelenting labor shortages force leaders to explore the practicality of leveraging
Read More
Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business
What You Should Know:
- Transcarent, a health and care experience company that makes it easy for people to access high-quality, affordable care announced it will acquire AI-powered virtual care platform and care business of on-demand primary care company, 98point6. Financial details of the acquisition were not disclosed; however, insiders expect the deal to be valued at $100M.
- As part of the acquisition, hundreds of 98point6 enterprise customers including Boeing, Kindercare and
Read More
Technology’s Role in the Development & Improvement of Drug Diversion Auditing Processes
Drug diversion is an increasingly serious issue that tends to be substantially underestimated. In every instance, a potential threat to patient safety is present. This includes the risk of inadequate pain relief, exposure to infectious diseases through contaminated needles or drugs, and risks associated with unsafe care from impaired healthcare workers. Drug diversion can also pose risks to staff safety and regulatory compliance, as can be seen across all types of healthcare facilities and,
Read More
The Market Demand for Data-Driven Tech Solutions in Healthcare
The market demand for data-driven technology solutions in healthcare is on the rise. Today, one-third of the world's data is generated by the healthcare industry. This data is often complex and is coming from multiple different sources such as personal health information, claims data, clinical trial data, patient surveys, disease registries, population health statistics, wellness apps, and wearable devices. And so, the need for data management technologies continues to grow. In the Future Health
Read More
Mayo’s Lucem Health Launches AI-Driven Early Disease Detection Platform
What You Should Know:
- Lucem Health™ today announced the availability of its new early AI-driven disease detection solutions, Lucem Health Reveal that leverages existing EHR data to identify patients who may be at a higher risk of serious or chronic disease.
- Reveal solutions surface previously undiscovered insights in readily available clinical data that can help provider organizations deliver greater clinical value for patients and more financial value to the organization.
Early
Read More
Tempus, Pfizer Partner to Advance Oncology Therapeutic Development
What You Should Know:
- Today, the AI-powered genetic testing and precision medicine company Tempus announced that it has signed a significant strategic agreement with Pfizer to more precisely gather insights that will inform novel drug discovery and development in oncology.
- Through this collaboration, Pfizer has access to Tempus’ AI-enabled platform and its library of de-identified, multimodal data to uncover insights that will power therapeutic development in oncology.
-
Read More
Stratasys, Ricoh Partner to Provide On-Demand 3D-Printed Anatomic Models for Hospitals and Clinics
What You Should Know:
- Stratasys Ltd. today announced they have signed another agreement with RICOH USA to provide on-demand 3D-printed anatomic models for clinical settings.
- The demand for additive manufacturing within the healthcare industry is continuously growing, and according to Grandview Research, the global healthcare additive manufacturing market size was valued at USD 1.6 billion in 2021 and is expected to expand at a compound annual growth rate of 22.6% from 2022 to 2030.
Read More
What Impact Could AI Have On Genetic Testing?
The sequencing and analysis of human DNA have advanced significantly since the initial draft of a human genome that was published as part of the Human Genome Project. With DNA sequencing becoming increasingly cost-effective, the market for genetic testing is growing at an accelerating rate – the market for Next Generation Sequencing (NGS) services has an estimated annual growth of 18.3% from 2022 to 2030. AI presents a range of possibilities for this rapidly growing field, and in this article,
Read More
